Skip to content

Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis

Nutritional Counseling in Systemic Immunoglobulin Light-chain (AL) Amyloidosis: a Prospective Randomized, Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02055534
Enrollment
144
Registered
2014-02-05
Start date
2007-07-31
Completion date
2013-09-30
Last updated
2025-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyloidosis

Brief summary

Poor nutritional status is common in patients with systemic immunoglobulin light-chain (AL) amyloidosis and has been associated with mortality and impaired quality of life (QoL). We investigated whether nutritional counseling is beneficial to the maintenance of nutritional status and QoL in AL outpatients.

Interventions

OTHERNutritional counseling

Nutritional counseling consists in: personalized dietary prescription associated with regular (every 3 weeks) dietetic advise by a registered dietician. Follow-up evaluations take place also during the visits scheduled by the oncologists

General dietary advices are provided. Follow-up evaluations take place during the visits scheduled by the oncologists

Sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Treatment naïve patients with with systemic immunoglobulin light-chain amyloidosis * Availability to planned measurements and to written informed consent

Exclusion criteria

* Age \< 18 years * Indication to organ transplantation * Indication to autologous stem cell transplantation * Need to start or ongoing dialysis * Ascites or massive edema * Need to start or ongoing artificial nutrition

Design outcomes

Primary

MeasureTime frameDescription
Body weight12 monthsChange in body weight at 12 months

Secondary

MeasureTime frameDescription
Quality of life12 monthsChange in quality of life at 12 months
Overall survival12 monthsOverall survival at the end of study

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026